Evaluation of National Highly Specialized Care for Adults With Treatment-Resistant Self-Harm and Eating Disorders: Substudy 1

Study acronym: NHV_ADULTS
StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Minor Study First Submitted
This study aims to evaluate National Highly Specialized Care (NHV) for adults with severe and treatment-resistant self-harm or eating disorders in Sweden. The study examines patients' and their significant others' experiences of care, the feasibility of the treatment programs, and changes in patients' symptoms and functioning during and after treatment. Participants receive specialized inpatient care or a combination of inpatient and intensive outpatient treatment, based on their individual clinical needs. Treatment typically lasts approximately 12 weeks but may vary depending on the patient's circumstances. Additional interventions may be provided to address co-occurring psychiatric conditions. Information is collected through self-report questionnaires, qualitative interviews, and clinical records. Patients and their significant others are invited to complete assessments during treatment and at follow-up, including up to five years after treatment. The findings are expected to contribute to improving specialized care for people with severe self-harm and eating disorders.
Trial Details
NCT Number NCT07878897
Lead Sponsor Karolinska Institutet
Conditions
(from sponsor)
Self-harm Behavior, Eating Disorders, Non-suicidal Self-injury (NSSI)
Related terms Feeding and Eating Disorders, Self-Injurious Behavior
Enrollment 250 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov